1 |
Kuroki, T., M. Shingu, Y. Koshihara, and M. Nobunaga. 1994. Effects of cytokines on alkaline phosphatase and osteocalcin production, calcification and calcium release by human osteoblastic cells. Br. J. Rheumatol. 33, 224-230
DOI
|
2 |
Guicheux, J., J. Lemonnier, C. Ghayor, A. Suzuki, G. Palmer, and J. Caverzasio. 2003. Activation of p38 mitogen-activated protein kinase and c-Jun-NH2-terminal kinase by BMP-2 and their implication in the stimulation of osteoblastic cell differentiation. J. Bone Miner. Res. 18, 2060-2068
DOI
ScienceOn
|
3 |
Gilbert, L., X. He, P. Farmer, S. Boden, M. Kozlowski, J. Rubin, and M. S. Nanes. 2000. Inhibition of osteoblast differentiation by tumor necrosis factor-alpha. Endocrinology 141, 3956-3964
DOI
ScienceOn
|
4 |
Teitelbaum, S. L. 2000. Bone resorption by osteoclasts. Science 289, 1504-1508
DOI
ScienceOn
|
5 |
Goldring, S. R. and E. M. Gravallese. 2000. Pathogenesis of bone erosions in rheumatoid arthritis. Curr. Opin. Rheumatol. 12, 195-199
DOI
ScienceOn
|
6 |
Stashenko, P., M. S. Obernesser, and F. E. Dewhirst. 1989. Effect of immune cytokines on bone. Immunol. Invest. 18, 239-249
DOI
|
7 |
Taichman, R. S. and P. V. Hauschka. 1992. Effects of interleukin-1 beta and tumor necrosis factor-alpha on osteo-blastic expression of osteocalcin and mineralized extracellular matrix in vitro. Inflammation 16, 587-601
DOI
|
8 |
Tracey, K. J. and A. Cerami. 1994. Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu. Rev. Med. 45, 491-503
DOI
ScienceOn
|
9 |
Vilcek, J. and T. H. Lee. 1991. Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. J. Biol. Chem. 266, 7313-7316
|
10 |
Ziros, P. G., A. P. Gil, T. Georgakopoulos, I. Habeos, D. Kletsas, E. K. Basdra, and A. G. Papavassiliou. 2002. The bone-specific transcriptional regulator Cbfa1 is a target of mechanical signals in osteoblastic cells. J. Biol. Chem. 277, 23934-23941
DOI
ScienceOn
|
11 |
Li, Y. P. and P. Stashenko. 1992. Proinflammatory cytokines tumor necrosis factor-alpha and IL-6, but not IL-1, down-regulate the osteocalcin gene promoter. J. Immunol. 148, 788-794
|
12 |
Manji, S. S., H. Zhou, D. M. Findlay, T. J. Martin, and K. W. Ng. 1995. Tumor necrosis factor alpha facilitates nuclear actions of retinoic acid to regulate expression of the alkaline phosphatase gene in preosteoblasts. J. Biol. Chem. 270, 8958-8962
DOI
ScienceOn
|
13 |
Merkel, K. D., J. M. Erdmann, K. P. McHugh, Y. Abu-Amer, F. P. Ross, and S. L. Teitelbaum. 1999. Tumor necrosis factor-alpha mediates orthopedic implant osteolysis. Am. J. Pathol. 154, 203-210
DOI
ScienceOn
|
14 |
Nakase, T., K. Takaoka, K. Masuhara, K. Shimizu, H. Yoshikawa, and T. Ochi. 1997. Interleukin-1 beta enhances and tumor necrosis factor-alpha inhibits bone morphogenetic protein-2-induced alkaline phosphatase activity in MC3T3-E1 osteoblastic cells. Bone 21, 17-21
DOI
ScienceOn
|
15 |
Panagakos, F. S. and S. Kumar. 1994. Modulation of proteases and their inhibitors in inunortal human osteoblast-like cells by tumor necrosis factor-alpha in vitro. Inflammation 18, 243-265
DOI
ScienceOn
|
16 |
Pittenger, M. F., A. M. Mackay, S. C. Beck, R. K. Jaiswal, R. Douglas, J. D. Mosca, M. A. Moorman, D. W. Simonetti, S. Craig, and D. R. Marshak. 1999. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143-147
DOI
ScienceOn
|
17 |
Prockop, D. J. 1997. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276, 71-74
DOI
|
18 |
Canalis, E. 1987. Effects of tumor necrosis factor on bone formation in vitro. Endocrinology 121, 1596-1604
DOI
ScienceOn
|
19 |
Short, B., N. Brouard, T. Occhiodoro-Scott, A. Ramakrishnan, and P. J. Simmons. 2003. Mesenchymal stem cells. Arch. Med. Res. 34, 565-571
DOI
ScienceOn
|
20 |
Barry, F. P. and J. M. Murphy. 2004. Mesenchymal stem cells: clinical applications and biological characterization. Int. J. Biochem. Cell Biol. 36, 568-584
DOI
ScienceOn
|
21 |
Caplan, A. I. 1991. Mesenchymal stem cells. J. Orthop. Res. 9, 641-650
DOI
|
22 |
Centrella, M., T. L. McCarthy, and E. Canalis. 1988. Tumor necrosis factor-alpha inhibits collagen synthesis and alkaline phosphatase activity independently of its effect on deoxyribonucleic acid synthesis in osteoblast-enriched bone cell cultures. Endocrinology 123, 1442-1448
DOI
ScienceOn
|
23 |
Chen, G. and D. V. GoeddeL 2002. TNF-R1 signaling: a beautiful pathway. Science 296, 1634-1635
DOI
ScienceOn
|
24 |
Clohisy, J. C., S. Teitelbaum, S. Chen, J. M. Erdmann, and Y. Abu-Amer. 2002. Tumor necrosis factor-alpha mediates polymethylmethacrylate particle-induced NF-kappaB activation in osteoclast precursor cells. J. Orthop. Res. 20, 174-181
DOI
ScienceOn
|
25 |
Farley, J. R. and B. Stilt-Coffing. 2001. Apoptosis may determine the release of skeletal alkaline phosphatase activity from human osteoblast-line cells. Calcif. Tissue Int. 68, 43-52
DOI
ScienceOn
|
26 |
Filvaroff, E. and R. Derynck. 1998. Bone remodelling: a signalling system for osteoclast regulation. Curr. Biol. 8, R679-R682
DOI
ScienceOn
|
27 |
Gerstenfeld, L. C., T. J. Cho, T. Kon, T. Aizawa, J. Cruceta, B. D. Graves, and T. A. Einhorn. 2001. Impaired intramembranous bone formation during bone repair in the absence of tumor necrosis factor-alpha signaling. Cells Tissues. Organs 169, 285-294
DOI
ScienceOn
|
28 |
Abbas, S., Y. H. Zhang, J. C. Clohisy, and Y. Abu-Amer. 2003. Tumor necrosis factor-alpha inhibits pre-osteoblast differentiation through its type-1 receptor. Cytokine 22, 33-41
DOI
ScienceOn
|
29 |
Beresford, J. N., J. H. Bennett, C. Devlin, P. S. Leboy, and M. E. Owen. 1992. Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures. J. Cell Sci. 102 (Pt 2), 341-351
|
30 |
Lee, R. H., B. Kim, I. Choi, H. Kim, H. S. Choi, K. Suh, Y. C. Bae, and J. S. Jung. 2004. Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. Cell Physiol Biochem. 14, 311-324
DOI
ScienceOn
|
31 |
Wajant, H., K. Pfizenmaier, and P. Scheurich. 2003. Tumor necrosis factor signaling. Cell Death. Differ. 10, 45-65
DOI
ScienceOn
|